«More research is needed
to evaluate the efficacy of this use of a cancer medication
to alleviate risk of sudden cardiac death, but we are hopeful that what we observed in mice will
translate effectively to humans, providing patients and clinicians with a new paradigm for treating this common and life - threatening illness,» Dudley said.